Targeted search of hypoglycemic agents among N-substituted isoindoline-1,3-diones and its analogues
DOI:
https://doi.org/10.14739/2409-2932.2018.1.123587Keywords:
carboxylic acids, molecular docking simulation, synthesis, magnetic resonance spectroscopy, hypoglycemic agentsAbstract
It is known, that increasing of glucose level in the blood is an important factor at the risk of vascular complications in diabetes mellitus type 2 development. Taking this into account, short-acting priming regulators of glycemia (meglitinides) are designed, such as tableted sugar-reducing drugs with short acting insulin secretion stimulation. They are characterized by a slight decrease of glycohemoglobin content, the risk of body weight gain and decrease of efficacy during long-term usage despite their effectiveness. The solution of this problem can be as following: the creation of more effective drugs, which would contain known antidiabetic “pharmacophore” fragments able to provide a long-term hypoglycemic effect and having a polyvectoral mechanism of activity and effect both on symptoms of the disease and on disease etiology.
The aim of the work is targeted search of hypoglycemic isoindoline-1,3-dione derivatives and its hydrogenated analogues based on rational design, structural similarity to metglitinides, molecular docking and traditional pharmacological screening.
Materials and methods: laboratory utensils and organic solvents, “Stuart Scientific SMP30” melting point apparatus, ELEMENTAR vario EL Cube elemental analyzer, Bruker ALPHA FT-IR spectrometer, Varian-Mercury 400 1H NMR spectrometer, Agilent 1100 Series liquid chromatograph, Marvin Sketch 17.21, AutoDockTools-1.5.6, Discovery Studio 4.0.
Results. The targeted search of hypoglycemic agents among N-substituted isoindoline-1,3-diones and its analogues based on the structural similarity with existing active pharmaceutical ingredients, using molecular docking and traditional pharmacological screening was performed in the work. Mentioned compounds were synthesized by the refluxing of phthalic anhydride and its analogs with aminoalkyl-(alkaryl-,aryl-)carboxylic acids in the medium of the acetic acid. It was shown, that refluxing of 3a,4,7,7a-tetrahydro-4,7-epoxyisobenzofuran-1,3-dione with glycine under the given conditions resulted the retro Diels-Alder reaction and formation of (Z)-4-((carboxymethyl)amino)-4-oxobut-2-enoic acid. Elemental analysis, chromatomass-, IR- and 1H-NMR spectral methods were used to prove the structure and individuality of the synthesized compounds.
Conclusion. A number of compounds were synthesized and chemically modified. Research of their hypoglycemic activity was carried out, that raveled a number of high active substances. Certain “structure – activity relations” were established and the perspective directions of their further chemical modification were substantiated.
References
Starkova, N. T. (2002) Klinicheskaya e'ndokrinologiya [Clinical endocrinology. Management]. Saint Petersburg: Piter [in Russian].
Michailov, V. V. (2001) Osnovy patologicheskoj fiziologii: Rukovodstvo dlya vrachej [Fundamentals of Pathological Physiology: A Guide for Physicians]. Moscow: Medicina [in Russian].
Sweeney, D., Raymer, M. L., & Lockwood, T. D. (2003) Antidiabetic and antimalarial biguanide drugs are metal-interactive anti-proteolytic agents. Biochemical Pharmacology, 66, 663–677. doi: 10.1016/S0006-2952(03)00338-1.
Jacob, J. (2013) Synthesis, Physico-chemical and Antidiabetic Studies of Zin Complex of Glimepiride, An Oral Hypoglycemic Agent. Orient. J. Chem., 29(4), 1351–1358. doi: http://dx.doi.org/10.13005/ojc/290410.
Arsia Tarnam, Y., Nargis Begum, T., Muhammad Ilyas, M. H., Shilu, Mathew, Archunan, Govindaraju, & Ishtiaq, Qadri. (2016) Green synthesis, Antioxidant Potential and Hypoglycemic Efect of Silver Nanoparticles using Ethanolic Leaf Extract of Clausena anisata (Willd.) Hook. F. Ex Benth. of Rutaceae. Pharmacognosy Journal, 8(6), 565–575. doi: 10.5530/pj.2016.6.8.
Coman, C., Rugina, O. D., & Socaciu, C. (2012) Plants and Natural Compounds with Antidiabetic Action. Not Bot Horti Agrobo, 40(1), 314–325.
Nouraddin, H., Soodeh, S., Mohamad, E., Mohammad, H., Mehdi., K., Saeed, F., et al. (2013) Synthesis and Antidiabetic Evaluation of Benzenesulfonamide Derivatives. Iranian Journal of Pharmaceutical Research, 12(2), 325–330.
Kecskemeti, V., Bagi, Z., Pacher, P., Posa, I., Kocsis, E., & Koltai, M. Z. (2002) New Trends in the Development of Oral Antidiabetic Drugs. Current Medicinal Chemistry, 9, 53–71. doi: 10.2174/0929867023371427.
Stefanova, О. V. (2001) Doklinichni doslidzhennіa likarskykh zasobiv [Preclinical studies of drugs]. Kyiv. [in Ukranian].
Zhao, L., Pan, Y., Peng, K., Wang, Z., Li, J., Li, D., et al. (2015) Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice. Journal of Molecular Endocrinology, 55(2), 119–131. doi: 10.1530/JME-14-0268.
Eckhardt, M., Langkopf, E., Mark, M., Tadayyon, M., Thomas, L., Nar, H., et al. (2007) 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. Journal of Medicinal Chemistry, 50(26), 6450–6453. doi: 10.1021/jm701280z.
Pourcet, B., Fruchart, J. C., Staels, B., & Glineur, C. (2006) Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis. Expert Opinion on Emerging Drugs, 11(3), 379–401. doi: 10.1517/14728214.11.3.379.
Trott, O., & Olson, A. J. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 31, 455–461. doi: 10.1002/jcc.21334.
Protein Data Bank. Retrieved from http://www.pdb.org.
MarvinSketch version 17.21.0, ChemAxon (http://www.chemaxon.com).
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)